Multiplex assays reveal anti‐EBV antibody profile and its implication in detection and diagnosis of nasopharyngeal carcinoma

Documenti analoghi

• The value of nasopharyngeal brush versus plasma EBV DNA detection in diagnosing local recurrence of nasopharyngeal carcinoma
  di: Yan‐Feng Ouyang, et al.
  Pubblicazione: (2026)
• Five‐year comparison of magnetic resonance imaging and endoscopy for nasopharyngeal carcinoma detection among high‐risk populations undergoing screening
  di: Hang‐Ning Zhou, et al.
  Pubblicazione: (2026)
• NAT10 inhibition promotes ac4C‐dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma
  di: Ziyi Xue, et al.
  Pubblicazione: (2024)
• Comparison of ≥2 lines immunotherapy regimens for recurrent/metastatic nasopharyngeal carcinoma
  di: Lan Peng, et al.
  Pubblicazione: (2026)
• Quality‐of‐life comparison between intensity‐modulated proton therapy and volumetric‐modulated arc therapy in patients with nasopharyngeal carcinoma: Preliminary findings from real‐world data
  di: Ching‐Nung Wu, et al.
  Pubblicazione: (2024)